[go: up one dir, main page]

DK3013366T3 - COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C1 INHIBITOR - Google Patents

COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C1 INHIBITOR Download PDF

Info

Publication number
DK3013366T3
DK3013366T3 DK14739078.5T DK14739078T DK3013366T3 DK 3013366 T3 DK3013366 T3 DK 3013366T3 DK 14739078 T DK14739078 T DK 14739078T DK 3013366 T3 DK3013366 T3 DK 3013366T3
Authority
DK
Denmark
Prior art keywords
inhibitor
combination therapy
factor xii
factor
xii inhibitor
Prior art date
Application number
DK14739078.5T
Other languages
Danish (da)
Inventor
Marc Nolte
Ingo Pragst
Original Assignee
Csl Behring Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Csl Behring Gmbh filed Critical Csl Behring Gmbh
Priority claimed from PCT/EP2014/063691 external-priority patent/WO2014207199A1/en
Application granted granted Critical
Publication of DK3013366T3 publication Critical patent/DK3013366T3/en

Links

DK14739078.5T 2013-06-28 2014-06-27 COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C1 INHIBITOR DK3013366T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361840662P 2013-06-28 2013-06-28
EP13176605 2013-07-16
PCT/EP2014/063691 WO2014207199A1 (en) 2013-06-28 2014-06-27 Combination therapy using a factor xii inhibitor and a c1-inhibitor

Publications (1)

Publication Number Publication Date
DK3013366T3 true DK3013366T3 (en) 2021-10-18

Family

ID=78230891

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14739078.5T DK3013366T3 (en) 2013-06-28 2014-06-27 COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C1 INHIBITOR

Country Status (1)

Country Link
DK (1) DK3013366T3 (en)

Similar Documents

Publication Publication Date Title
IL272921A (en) Combination therapy comprising a b-raf inhibitor and a second inhibitor
PL3013366T3 (en) Combination therapy using a factor xii inhibitor and a c1-inhibitor
DK3027209T3 (en) Anti-Activin A Antibodies and Uses thereof
DK3043784T3 (en) ARYLETES AND USES THEREOF
IL259479B (en) Cancer treatment using 2-deoxy-2-fluoro-l-fucose in combination with a checkpoint inhibitor
EP2949343A4 (en) TRIDENTED CONNEXON AND USE THEREOF
DK3003039T3 (en) METHYL / FLUOR-PYRIDINYL-METOXY-SUBSTITUTED PYRIDINON-PYRIDINYL-COMPOUNDS AND FLUOR-PYRIMIDINYL-METOXY-SUBSTITUTED PYRIDINON-PYRIDINYL-CONNECTIONS
LT3080100T (en) LYSINE-SPECIFIC DEMETHYLASE-1 INHIBITORS
DK2968443T3 (en) HEPCIDINE ANALOGS AND USES THEREOF
DK3777595T3 (en) INTEGRATED CLOSURE COMPONENTS AND METHODS
EP2978425A4 (en) XIA FACTOR INHIBITORS
DK3381917T3 (en) IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
DK3240952T3 (en) ANTI-TURNOVER PROTECTION DEVICE AND TECHNOLOGY FOR SECURING WINDMILL LIVES AGAINST TURNS
DK3063144T3 (en) ANTIPARASITARY AND PESTICID-ISOXAZOLINE COMPOUNDS
EP2985313A4 (en) ACRYLIC RESIN FILM
DK3074716T3 (en) A PROJECTILE
DK2962100T3 (en) TUBERCULOSEBIOMARKEARS AND USES THEREOF
DK3363805T3 (en) Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
DK2909182T3 (en) PREPARATION AND FORMULATION INCLUDING A MEK INHIBITOR
DK3030549T3 (en) PYRIDAZINON COMPOUNDS AND USES THEREOF
DK3029038T3 (en) TETRAZOLINON CONNECTION AND USE THEREOF
DK2964374T3 (en) SYNTHESIS DEVICE AND PROCEDURE
NO344969B1 (en) Underwater device and procedure
FI20135910L (en) Electronic display for underwater use
DK2941268T3 (en) SELECTIVE NOX-1 INHIBITOR PEPTIDES AND USES THEREOF